The previous studies demonstrated that FCGR3 on myeloid cells promoted CD40 antibody-mediated maturation of dendritic cells and activation of CD8+ T cells, and thereby drove the anti-tumor activity of agonistic CD40 antibodies [20]. Here, CD8A is linked to neoplasm.